Agios Pharmaceuticals (AGIO) Current Leases (2019 - 2026)
Agios Pharmaceuticals (AGIO) posted Current Leases of $18.8 million for Q1 2026, up 2.25% on a QoQ basis from $18.4 million in Q4 2025, and up 9.36% year-over-year from $17.2 million in Q1 2025.
Agios Pharmaceuticals (AGIO) Current Leases (2019 - 2026) Analysis & Trends
Agios Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $18.8 million for Q1 2026.
- Quarterly Current Leases rose 9.36% year-over-year to $18.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.8 million (up 9.36% YoY) and the FY2025 annual result came in at $18.4 million, up 9.6% from the prior year.
- Current Leases was $18.8 million for Q1 2026 at Agios Pharmaceuticals, up from $18.4 million in the prior quarter.
- Across five years, Current Leases topped out at $18.8 million in Q1 2026 and bottomed at $83000.0 in Q3 2022.
- A 5-year average of $13.3 million and a median of $15.4 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases slumped 99.16% — and 2023, when it soared 17567.47%.
- Agios Pharmaceuticals' Current Leases stood at $13.7 million in 2022, then rose by 9.84% to $15.0 million in 2023, then climbed by 11.81% to $16.8 million in 2024, then advanced by 9.6% to $18.4 million in 2025, then rose by 2.25% to $18.8 million in 2026.
- Business Quant data shows AGIO's Current Leases at $18.8 million in Q1 2026, $18.4 million in Q4 2025, and $18.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 18.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.81 Mn |
| Dec 31, 2025 | 18.39 Mn |
| Sep 30, 2025 | 17.99 Mn |
| Jun 30, 2025 | 17.59 Mn |
| Mar 31, 2025 | 17.20 Mn |
| Dec 31, 2024 | 16.78 Mn |
| Sep 30, 2024 | 16.32 Mn |
| Jun 30, 2024 | 15.86 Mn |
| Mar 31, 2024 | 15.41 Mn |
| Dec 31, 2023 | 15.01 Mn |
| Sep 30, 2023 | 14.66 Mn |
| Jun 30, 2023 | 14.33 Mn |
| Mar 31, 2023 | 13.99 Mn |
| Dec 31, 2022 | 13.66 Mn |
| Sep 30, 2022 | 83,000.00 |
| Jun 30, 2022 | 167,000.00 |
| Mar 31, 2022 | 250,000.00 |
| Dec 31, 2021 | 10.83 Mn |
| Sep 30, 2021 | 9.88 Mn |
| Jun 30, 2021 | 839,000.00 |